HOME >> MEDICINE >> NEWS
New substance that improves the photodetection of bladder cancer gains market approval

Scientists at the Ecole Polytechnique Fdrale de Lausanne (EPFL), in collaboration with Lausanne's University Hospital and Lausanne University's Physiology Department, have invested more than ten years of research into the development of a fluorescence-inducing compound that may very well revolutionize the photodetection of superficial bladder cancer.

This substance, hexaminolevulinate, is the active substance in a new pharmaceutical product that has been developed by the Norwegian company PhotoCure ASA. The new product will be sold under the name Hexvix. Photocure ASA won approval March 2 for market release of Hexvix in 26 European countries.

Every year, nearly 200,000 cases of bladder cancer are reported in Europe and the United States. In the US alone, more than 2.5 million screenings take place every year. If caught early, the five-year survival rate from this disease is an encouraging 90%. This drops to 50% when the cancer is locally metastasized and to about 10% for distant metastasis. Catching and treating bladder cancer as quickly as possible is clearly critical for a favorable outcome.

In its early stages, bladder cancer is characterized by superficial tumors or lesions. In conventional screening, a cystoscope is used to visually examine the inside of the bladder, and suspected tumors are removed for biopsy. Upon positive diagnosis, the cystoscope is used again as a surgeon or physician visually identifies and cuts out the cancerous tissue. This "white light" examination and resection is quite difficult for flat lesions and the experience of the individual urologist or surgeon is a considerable variable factor in successful detection. The recurrence rate under this treatment is quite high, and is thought to be due in part to superficial lesions or small tumors that are overlooked during the initial screening and diagnosis.

The use of hexaminolevulinate (HAL) in detection of bladder cancer was initiated by Hubert van den Bergh,
'"/>

Contact: Mary Parlange, science writer
mary.parlange@epfl.ch
41-21-693-7022
Ecole Polytechnique Fdrale de Lausanne
2-Mar-2005


Page: 1 2 3

Related medicine news :

1. Study finds factors linked to substance use disorder relapse among health care professionals
2. ER patients with substance abuse treatment need incur higher health care costs
3. Premature infants with lung disease may continue to need replacement substance to ease breathing
4. Pediatricians often underestimate substance abuse problems in adolescents
5. UMHS researchers help hone use of substance to improve lung function in premature infants
6. Sleep problems in early childhood may predict substance use during adolescence
7. Computer-assisted cognitive rehabilitation improves substance-abuse treatment response
8. Survival sex and substance abuse may hinder HIV prevention efforts
9. Study finds few substance abuse treatment programs for elders
10. Severe childhood ADHD may predict alcohol, substance use problems in teen years
11. Rensselaer awarded NY state funding for alcohol/substance abuse education

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
Cached News: